BPTP Limited, through its wholly owned subsidiary Urban Realtech Private Limited, has entered into a joint development arrangement with the landowner for development of a residential group housing project on an approximately 11-acre land parcel in Sector 39, Surajkund, Faridabad.

BPTP Enters Joint Development for 11 Acre Residential Project in Surajkund, Faridabad

The subject plot, measuring approximately 11 acres, is located in Sector 39, Surajkund, Faridabad, and benefits from proximity to established infrastructure and connectivity to key NCR corridors. The proposed project is expected to have a potential developable area of more than 2 million square feet. The development will be undertaken upon receipt of applicable statutory and regulatory approvals, including permissions from the Department of Town & Country Planning, Haryana, and registration under the Real Estate (Regulation and Development) Act, 2016, as applicable.

Commenting on the development, Kabul Chawla, Chairman and Managing Director, BPTP Limited, said, “We believe, Faridabad continues to demonstrate structural growth momentum, supported by improving connectivity and evolving residential demand patterns. Surajkund, in particular, stands out as a differentiated micro-market with long-term potential owing to its established ecosystem and natural setting.

This development is aligned with our calibrated strategy and reinforces our continued focus on markets where we have deep operating experience. With our longstanding presence in Faridabad, we remain committed to contributing meaningfully to the region’s residential landscape.

The proposed group housing development is intended to reflect contemporary urban design principles while being sensitive to the natural and cultural character of Surajkund. We aim to create a thoughtfully planned community that aligns with evolving consumer aspirations and sustainable development considerations. We believe this project has the potential to further strengthen our regional portfolio and enhance long-term stakeholder value.”

About BPTP Limited

BPTP Limited is one of NCR’s leading real estate developers with over two decades of operations in the Delhi-NCR region. The group has successfully delivered numerous residential and commercial projects across multiple locations in NCR, including residential group housing, plotted developments, commercial developments and integrated townships.

World Nutella® Day is celebrated by millions of fans worldwide who share their “Nutella Moments’ on 5th February each year. This year’s celebration was especially significant with the launch of a coffee table edition of Nutella by the prestigious publishing house Assouline and is the first-ever book dedicated to a food brand by Assouline.

(L to R): H.E. Mr. Antonio Bartoli, Ambassador of Italy to India, Mr. Hamid Touil, Managing Director, Ferrero India and H.E. Mr. Christian Biever, Ambassador of Luxembourg to India

In India, the milestone was recently celebrated with the unveiling of the Assouline Nutella Coffee Table Book by His Excellency Mr. Antonio Bartoli, Ambassador of Italy to India, His Excellency Mr. Christian Biever, Ambassador of Luxembourg to India and Mr. Hamid Touil, Managing Director, Ferrero India. The celebration took place at Italian Embassy, marking 60+ Years of Nutella and World Nutella Day.

Nutella Coffee Table Book by Assouline

The event was graced by senior leaders, industry stalwarts, content creators, chefs, and key opinion leaders. The warm and intimate setting fostered meaningful conversations and cultural exchange, reflecting Nutella’s rich heritage and global appeal.

Designed as a premium coffee table edition, Nutella by Assouline traces over 60 years of history across six chapters — History, Quality, Bread & Breakfast, Multiplicity of Uses, Nutella in the World, and Iconicity. The book captures how Nutella has evolved into a true cultural phenomenon, inspiring traditions, creativity, and shared family moments across generations.

The celebration in India reinforced Nutella’s timeless appeal, cultural resonance, and continued evolution as a global Power Brand.

The 7th International Conference on Birth Defects (ICBD 2026), held in Pune served as a monumental gathering of national and level genetics experts dedicated to the theme of integrative healthcare and the prevention of congenital anomalies.

Dignitaries and global experts at the 7th International Conference on Birth Defects

Hosted by the Department of Paediatrics at Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune in association with the South Asia Genomic Healthcare Alliance and the Genomic Medicine Foundation UK, the event was meticulously orchestrated by a visionary organizing team including Organizing Chairperson Dr. Shailaja Mane, Dr. Pramila Menon, Dr. Parag M Tamhankar, Dr. Sneha Sagarkar and Dr. Aradhana Dwivedi. The conference was made possible through the steadfast leadership of Hon’ble Chancellor Dr. P. D. Patil, Hon’ble Pro-Chancellor Dr. Bhagyashree P. Patil, Hon’ble Trustee and Treasurer Dr. Yashraj P. Patil and Dean Dr. Rekha Arcot, who emphasized the necessity of bridging the gap between high-end genomic research and bedside clinical care.

The Workshop on Applied Clinical Genomics: Hands-on Analysis of Exome Sequencing Data and Reporting integrated advanced genomic medicine with public health priorities, closely aligning with UNICEF’s mandate to reduce preventable birth defects, improve early diagnosis and strengthen maternal and child health systems. Dr. Parag Tamhankar (Consultant Geneticist), Prof. Shiji Chalipat (Paediatric Neurology), Dr. Supriya Gupte (Paediatric Endocrinology) and Sarita Varma (Paediatric Haematologist) contributed to case discussions, while Dr. Dipti Deshpande of Semantic Webtech analysed the exomic data.

The workshop trained clinicians, paediatricians and researchers in Human Phenotype Ontology (HPO) usage, variant interpretation and reporting, trio exome analysis and management of uncertain genomic findings, strengthening sustainable genomic expertise within India’s healthcare system and supporting equitable access to advanced diagnostics.

A dedicated UNICEF Public Forum on Birth Defects and panel discussion brought together senior clinical geneticists, public health experts and UNICEF representatives to bridge the gap between genomic science and community-level implementation. Simin Irani UNICEF Consultant explained the importance of maternal nutrition.

Dr. Pramila Menon sensitized the community health workers about detection of birth defects and preventive strategies. Dr. Gopal Kadam shared his experience about management of birth defects in Hingoli district of Maharashtra. The panellists included Dr. H.H. Chavan, Medical Superintendent of Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune; Dr. Shailaja Mane; Dr. Varsha Dange; Mrs. Manisha Biraris CDPO PCMC Pune and Dr. Dhavendra Kumar, Genomic Medicine Foundation UK. He appreciated the progress of Maharashtra for diagnosing and treatment of birth defects. The session was in alignment with UNICEF Priorities for prevention of birth defects.

Across three days, scientific discourse was enriched by Professor Dr. Dhavendra Kumar from Genomic Foundation, UK, who examined inherited factors in congenital heart disease and Professor Mieke van Haelst, who presented groundbreaking work on genetic obesity and DNA methylation episignatures as diagnostic biomarkers for Fetal Alcohol Syndrome. Professor Diana Baralle from University of Southampton and Professor Emma Baple from University of Exeter highlighted advances in genomic and multi-omic diagnostics aimed at ending the “diagnostic odyssey” for families.

The Gregor Mendel Oration was delivered by Padma Shri Dr. K. Thangaraj, who traced the journey from population genetics to personalized medicine in India, while Dr. Shubha Phadke shared practical clinical insights for settings where whole exome sequencing is not always accessible. Maternal and environmental influences were addressed by Dr. Simin Irani of UNICEF, who emphasized maternal nutrition and Dr. Chittaranjan Yajnik, who discussed nutritional teratogenesis and fetal programming as drivers of later-life chronic disease.

Additional expert perspectives were provided by Dr. Ashwin Dalal on genetic diagnostic services, Dr. Pramila Menon on birth defects and genetic epilepsy and Dr. Aradhana Dwivedi on lysosomal storage diseases. Specialized insights on rare diseases and neonatal care were shared by Dr. Mohnish Suri, Dr. Koumudi Godbole, Dr. Chaitanya Datar, Dr. Gopal Kadam, Dr. Vaibhav Upadhyay, Dr. Vinod Scaria, Dr. Meenal Agarwal and Dr. Anup Rawool.

Dr. Mohnish Suri, Consultant Clinical Geneticist at the Nottingham Clinical Genetics Service, Nottingham University Hospitals NHS Trust, spoke online on “The UK National Paediatric Ataxia-Telangiectasia Clinic: An Exemplar for Multidisciplinary Management of a Rare, Multisystem Genetic Disorder.” Dr. Mrudula Phadke, former Vice Chancellor of MUHS and Senior UNICEF Consultant, addressed the impact of maternal illnesses, adolescent nutrition and the triple burden of malnutrition in contributing to birth defects.

A defining feature of the conference was its strong social impact, reflected in the participation of Anganwadi workers who attended public lectures on early detection and community-level prevention. This bridge between cutting-edge science and grassroots health was supported by global patron UNICEF. The event concluded with participants reaffirming their commitment to decoding the human genome to ensure healthier futures for children.

Hon’ble Dr. P. D. Patil, Chancellor, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, stated, “Congenital anomalies continue to place a considerable burden on healthcare systems worldwide. Effective management extends beyond treatment to include prevention strategies, early identification, multidisciplinary care and continued research. A collective academic effort is essential to ensure meaningful progress in reducing their overall impact.”

Hon’ble Dr. Bhagyashree P. Patil, Pro-Chancellor, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune remarked, “Advances in medical genetics, prenatal diagnostics and neonatal care have significantly expanded our ability to recognize congenital conditions earlier and manage them more effectively. Academic forums such as this conference are vital in translating these advances into accessible and coordinated care.”

Hon’ble Dr. Yashraj P. Patil, Trustee and Treasurer, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, said, “Strengthening preventive care, improving access to early screening and promoting evidence-based interventions are critical steps toward addressing the long-term impact of birth defects. Platforms that encourage dialogue on practical solutions and emerging knowledge play a key role in advancing this mission.”

Dr. Rekha Arcot, Dean, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pimpri, Pune emphasized, “A birth defect may clinically represent a change in a gene or a chromosome, but for a family, it is profoundly life-changing. Families must grapple with the reality of raising a child born with a defect, which completely reshapes their social interactions and lived experiences. It also has significant implications for the economics of healthcare delivery. When we speak of defects that are not surgically correctable or conditions for which clear care guidelines do not yet exist, the burden often becomes lifelong. I am particularly delighted that Anganwadi workers were part of our discussions yesterday, as they are the frontline link with families at the primary healthcare level and play a crucial role in early identification of birth defects. Medical college institutions carry a unique responsibility and privilege to bring together diverse stakeholders and disciplines to deliver truly integrated care for these children. Truly this is where science touches the soul and high technology transforms into high touch.”

Dr. Shailaja Mane, Professor & Head, Department of Paediatrics, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pimpri, Pune, added, “This conference offered a dynamic platform for meaningful dialogue and knowledge exchange. The insights and practical perspectives shared by eminent experts made it a truly enriching academic endeavour for all participants.”

About Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune

Dr. D. Y. Patil Medical College, Hospital &Research Centre, Pimpri, Pune follows international benchmarks that are performance-driven as well as patient-centric, strongly backed by evidence-based medical expertise. We are NABH and NABL accredited and have been certified as a Green Hospital by the Association of Healthcare Providers India (AHPI). Additionally, we hold the 12th rank in the National Institutional Ranking Framework (NIRF). The university has been awarded A++ status by the National Assessment and Accreditation Council (NAAC) and is an ISO 2015 certified organization (ISO 9001: 2015).

For more information visit medical.dpu.edu.in

Facebook: Dr D Y Patil Medical College, Hospital and Research Centre

Instagram: dpu.medicalcollege

Receiving a sudden windfall—be it a year-end bonus, family inheritance, or proceeds from selling an asset—may nudge an investor to review their financial strategy. By investing this surplus money, one can potentially enhance their corpus and earn higher potential returns. This article walks you through ways in which you may plan your investments after receiving a lumpsum and how a lumpsum calculator may aid this process. 

How to Plan Investments After Receiving a Bonus, Inheritance, or Asset Sale

Assess the surplus
Before diving into investments, pause to evaluate the funds at hand. Calculate your net amount after taxes and essentials: bonuses may attract TDS, inheritances may involve probate fees or estate duties, and asset sales may trigger capital gains tax. Investors may use part of the windfall to build an emergency fund covering 6-12 months’ expenses through an overnight or liquid mutual fund to have convenient access to their money. They may also use some money to pay off high-interest debts such as credit cards. After this, the remaining sum could then be allocated strategically to align with their long-term financial objectives.

Lumpsum vs SIP: Core strategies
Deploying a windfall may demand choosing between lumpsum investing and SIP investment routes, each suiting different risk profiles and market views. A lumpsum calculator may be of help here—it simulates growth potential by inputting your bonus amount, expected rate of annual return, and time horizon of the investment. Investors may use free lumpsum calculators to assess various scenarios.

SIP investment, conversely, involves dividing the sum into monthly/quarterly instalments, mitigating timing risk via rupee-cost averaging. Investors could also adopt a hybrid approach by investing 50% of the surplus as lumpsum and the rest in an SIP.

Use a lumpsum calculator for precision
A lumpsum calculator helps demystify one-shot investing by projecting the potential projecting future using the compound interest formula:
A = P X (1+r)^n

Where:

• A = Final value of investment

• P = Initial investment amount (Principal)

• r = Annualized rate of return (in decimal, e.g., 10% = 0.10)

• n = Number of years

For example, if you invest Rs. 1,00,000 in a fund for five years and expected returns of 12% per annum.

A = 1,00,000 × (1+0.12)^5
A = 1,00,000 X 1.76
A = Rs. 1.76 lakh

Example for illustrative purposes only.

These figures are illustrative, not guaranteed, as markets fluctuate. However, the tool may help investors take data-driven and more informed decisions. 

The calculator is an aid, not a prediction tool. It may provide only an indicative picture. 

Practical steps 
Here are steps you may follow when investing an extra inflow of money. 

1. Define goals: Retirement? Children’s education? You may list timelines and required corpus via goal-based calculators.
2. Run simulations: You may use lumpsum and SIP calculators to review various scenarios.
3. Invest: You may choose funds and an allocation strategy that aligns with your investment objectives and risk appetite.
4. Review annually: It is advised to review and rebalance investments regularly to maintain a suitable asset mix.
5. Seek advice: You may consult professional advisers for personalised plans and further guidance.

Conclusion
Receiving a windfall through a bonus, inheritance, or asset sale may mark a moment of investment reassessment in an investor’s journey. Thoughtful deployment of these extra funds may help you enhance your potential corpus. 

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.

Indraprastha Apollo Hospitals has launched the Varian Edge® Radiosurgery System with Hyperarc Technology, strengthening its advanced cancer care capabilities and expanding treatment options for complex and hard-to-reach tumours.

Indraprastha Apollo Hospitals launches Varian Edge radiosurgery system

The introduction of the Varian Edge® system marks a significant milestone in radiation oncology, combining precision and advanced motion management to deliver highly targeted radiation therapy while minimising exposure to surrounding healthy tissue. The technology enables doctors to treat tumours even as they move during breathing, ensuring consistent accuracy throughout treatment.

The platform also supports advanced motion-management techniques such as Deep Inspiration Breath Hold (DIBH), which is particularly beneficial in left-sided breast cancers by helping reduce radiation exposure to the heart. Its enhanced imaging clarity further strengthens precision in abdominal, liver, lung, gastrointestinal and genitourinary tumours, where internal organ movement and gas interference can otherwise impact treatment accuracy.

A key clinical advantage of the Varian Edge® platform is its ability to treat multiple metastases in a single session, often reducing overall treatment time to less than one-third of conventional LINAC or SRS treatments. The system’s synchronised movement of the radiation beam and treatment couch allows for continuous, precise radiation delivery, resulting in fewer radiation “hits” and improved patient comfort.

Dr G.K. Jadhav, Senior Consultant, Radiation Oncology, Indraprastha Apollo Hospitals, noted, “The Varian Edge platform gives us a sharper and more versatile tool to manage a wide spectrum of tumours from tiny lesions to large, complex cases, even in challenging locations. It meaningfully expands our treatment options and enhances clinical outcomes.”

Dr Sapna Manocha Verma, Senior Consultant, Radiation Oncology, Indraprastha Apollo Hospitals, added, “What sets apart this technology is the radiation beam continuously tracks and adjusts to the tumour’s position, even as it shifts during breathing, while surrounding healthy tissue is carefully protected. The platform also supports advanced motion-management techniques such as Deep Inspiration Breath Hold (DIBH), which is particularly beneficial in left-sided breast tumours and in select liver and lung tumours. For patients, this translates into shorter treatment times, fewer side effects, and faster recovery.”

Dr Robin Khosa, Senior Consultant, Radiation Oncology, Indraprastha Apollo Hospitals, said, “The Varian Edge® Radiosurgery System with Hyperarc Technology represents a major advancement in precision radiation therapy. Its ability to track tumours in real time and deliver radiation with submillimetre accuracy allows us to treat complex cases including multiple brain metastases and tumours previously considered difficult or untreatable with greater safety and confidence.”

The launch was also marked by the presence of Dr Mano Bhadauria, Senior Consultant, Radiation Oncology; Dr Aditi Agarwal, Senior Consultant, Radiation Oncology, Indraprastha Apollo Hospitals; and Dr Devashish Tripathi, Senior Consultant in Radiation Oncology at Apollo Hospitals, New Delhi.

The system is particularly impactful in treating tumours located in delicate or hard-to-reach areas, where precision and motion management are critical. Enhanced imaging quality, sharper resolution, and improved accuracy enable clinicians to reduce treatment margins, safely deliver higher radiation doses when required, and potentially improve cure rates while lowering normal tissue toxicity.

With the launch of the Varian Edge® Radiosurgery System, Indraprastha Apollo Hospitals continues to reinforce its commitment to combining cutting-edge technology with deep clinical expertise. Backed by a multidisciplinary team of oncologists, neurosurgeons, physicists, and radiation specialists, the hospital remains focused on pushing the boundaries of what is possible in cancer care ensuring better outcomes, fewer side effects, and more time for patients to focus on living.

About Indraprastha Apollo Hospitals

Indraprastha Apollo Hospitals, India’s first JCI accredited hospital, is a joint venture between the Government of Delhi and Apollo Hospitals Enterprise Limited. Commissioned in July 1996, it is the third super-specialty tertiary care hospital set up by the Apollo Hospitals Group. Spread over 15 acres, it houses 57 specialties with more than 300 specialists and more than 700 operational beds, 19 operation theatres, 138 ICU beds, round-the-clock pharmacy, NABL accredited laboratories, 24-hour emergency services and an active air ambulance service. Apollo Hospitals Delhi has the leading programme in kidney and liver transplant in the country. The first successful paediatrics and adult liver transplants in India were performed at Indraprastha Apollo Hospitals. The hospital is at the forefront of medical technology and expertise. It provides a complete range of latest diagnostic, medical and surgical facilities for the care of its patients. The Hospital has introduced the most sophisticated imaging technology to India with the introduction of 64 slice CT and 3 Tesla MRI, Novalis Tx and the integrated PET Suite.

In a groundbreaking advancement, Indraprastha Apollo Hospitals has recently introduced the ZAP-X Gyroscopic Radiosurgery Platform, revolutionizing brain tumor treatment across South Asia. This state-of-the-art technology offers a non-invasive alternative to traditional brain surgery, promising improved patient outcomes and comfort. Backed by the experience and expertise of Radiation Oncologists and technical team, Indraprastha Apollo also brings the revolutionary RADIXACT – X9 that combines imaging and treatment delivery to precisely target a wide variety of Cancers.

Indraprastha Apollo has pioneered the concept of preventive health check programmes and has created a satisfied customer base over decades. The Hospital has been consistently ranked amongst the best 10 hospitals in India by The Week survey for the past few years.

Hospital website – www.apollohospitals.com/hospitals/apollo-hospitals-delhi

Twitter: @HospitalsApollo

Tourism Malaysia reaffirmed its strong commitment to the Indian outbound market at a high-level press conference held in New Delhi today, ahead of its participation in SATTE 2026.

L to R: Nuwal Fadhilah Ku Azmi, Senior Director, Dato Muzafar Shah Mustafa, High Commissioner of Malaysia to India, Datuk Manoharan Periasamy, Chairman – Tourism Malaysia, Ahmad Johanif Mohd Ali, Director, Tourism Malaysia-Delhi

The press conference was addressed by YBhg. Datuk Manoharan Periasamy, Chairman of Tourism Malaysia, alongside Dato’ Muzafar Shah Mustafa, High Commissioner of Malaysia to India, in the presence of leading travel trade partners, airline representatives, tourism stakeholders, and media.

Malaysian cultural dance

The engagement comes at a significant time as Malaysia accelerates its global outreach under Visit Malaysia Year 2026 (VM2026).

Strong Performance and Market Momentum
Malaysia recorded 42.2 million international visitor arrivals in 2025, reflecting an 14.6% growth over 2024. India remains one of Malaysia’s most dynamic source markets, contributing over 1.6 million visitors in 2025, demonstrating sustained demand and market confidence.

L to R: Nuwal Fadhilah Ku Azmi, Senior Director, Datuk Manoharan Periasamy, Chairman-Tourism Malaysia, Dato Muzafar Shah Mustafa, High Commissioner of Malaysia to India, Ahmad Johanif Mohd Ali, Director, Tourism Malaysia-Delhi

Speaking at the press conference, YBhg. Datuk Manoharan Periasamy, Chairman of Tourism Malaysia, said “India continues to play a pivotal role in Malaysia’s international tourism strategy. The robust growth in Indian arrivals reflects the strong bilateral ties and growing consumer confidence in Malaysia as a safe, diverse and high-value destination. As we move closer to Visit Malaysia Year 2026, we are intensifying strategic collaborations with our Indian partners to drive sustainable and high-yield tourism growth.”

Highlighting ground-level engagement and trade partnerships, Dato’ Muzafar Shah Mustafa, High Commissioner of Malaysia to India added “The Indian market has shown remarkable resilience and enthusiasm for Malaysia across leisure, MICE, weddings and premium travel segments. With expanded air connectivity, continued visa-free entry for Indian nationals, and strong industry partnerships, we are confident of achieving even stronger growth in 2026. Our focus remains on delivering quality experiences while strengthening trade collaboration across Tier I, II and III cities.”

Enhanced Connectivity and Accessibility
With more than 240 weekly flights operating between India and Malaysia, coupled with the continuation of visa-free entry for Indian nationals, travel accessibility remains robust and supportive of further growth under the Visit Malaysia 2026 (VM2026) campaign.

Strategic Engagement Events on 24 February 2026
As part of its intensive market outreach on 24 February 2026, Tourism Malaysia is organizing three dedicated engagement events in New Delhi ahead of SATTE 2026:

Wedding Seminar – Positioning Malaysia as a premier destination for grand Indian weddings, highlighting luxury venues, culturally adaptable services, seamless logistics and competitive value offerings.

MICE B2B Session – Facilitating direct business engagements between Malaysian industry players and Indian corporate planners and event organizers, showcasing Malaysia’s capabilities in Meetings, Incentives, Conferences and Exhibitions (MICE).

Malaysia Networking Dinner 2026 – An exclusive evening bringing together leading travel trade partners, airline representatives, wedding planners, corporate stakeholders and media to strengthen bilateral cooperation, foster new partnerships and build sustained momentum towards VM2026.

For more information on Malaysia’s tourism offerings, visit www.malaysia.travel.

About Tourism Malaysia
Malaysia Tourism Promotion Board, also known as Tourism Malaysia, is an agency under the Ministry of Tourism, Arts and Culture Malaysia (MOTAC). It focuses on promoting Malaysia as a preferred tourism destination and has, since its establishment, played a significant role in strengthening the country’s presence and competitiveness in the global tourism landscape.

Visit Malaysia 2026 (VM2026) underscores Malaysia’s commitment to sustainable tourism development, in line with the United Nations Sustainable Development Goals (UNSDGs). The campaign aims to showcase the nation’s diverse natural attractions, rich cultural heritage, and vibrant tourism offerings, while driving inclusive growth and long-term value for local communities and industry stakeholders.

For more information, visit Tourism Malaysia’s website at www.tourism.gov.my and social media accounts on Facebook, Instagram, X, YouTube, and TikTok.

Leading global risk, security, and intelligence firm IIRIS has signed a Memorandum of Understanding (MoU) with the National Law University, Jodhpur formalising the establishment of the IIRIS Chair of Infosec and Forensic Society. First in India, this Chair intends to create a vibrant center of excellence that fosters a culture of research, innovation, and industry-academia collaboration in the fields of information security and forensic science.

IIRIS signs MoU with National Law University, Jodhpur to establish the IIRIS Chair of Infosec and Forensic Society and launch a joint certificate programme in cyber forensics

The MoU also announces a joint Certificate Programme on Cyber-Led Forensic Investigation and Diligence, focused on building future-ready skills at the intersection of law, technology, and investigations. The programme, under the guiding theme ‘Bridging Legal Theory & Investigative Practice in the Digital Age,’ is designed to equip participants with concrete competencies for professional practice.

The MoU signing ceremony was graced by Ms. Sagarika Chakraborty, CEO, IIRIS and Prof. Dr. Harpreet Kaur, Hon’ble Vice Chancellor, NLU Jodhpur.

Commenting on the partnership with NLUJ, Ms. Chakraborty said, “This partnership brings together two institutions with complementary strengths. NLUJ brings profound expertise in legal theory and the jurisprudential foundations of justice. IIRIS brings cutting-edge investigative practice and real-world experience across more than a decade of operations in over ten countries. Together, we are creating a sustained interface between the academy and industry, between theory and practice.” 

Prof. (Dr.) Harpreet Kaur, Vice Chancellor, National Law University, Jodhpur, said, “Skills for future litigation and other legal works are required to be inculcated in budding lawyers. Law universities need to be cognisant of the fact that present-day skills might not be sufficient later. NLU Jodhpur signed this MoU with IIRIS for skilling its students both by teaching and researching for cyber-led forensic investigations and diligence. The MoU is in alignment with the focus of the university in Law and Technology interface.”

This collaboration is founded on the conviction that legal theory is not merely foundational but is the critical intellectual framework that ensures investigations are just, ethical, and legally sound.